Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2%.
The iShares Biotechnology ETF (IBB) rose 0.9%.
In corporate news, Alkermes (ALKS) stock has been re-rated following a recent orexin-peer takeout, but upcoming orexin updates risk eroding newly ascribed orexin-related value, BofA Securities said in a research note Monday. BofA downgraded Alkermes to underperform from neutral with a price target of $38. Alkermes shares were down 4.6%.